Should You Buy Pain Therapeutics, Inc. (PTIE)?: Cytokinetics, Inc. (CYTK), ArQule, Inc. (ARQL)

Pain Therapeutics, Inc. (NASDAQ:PTIE) has experienced an increase in hedge fund interest of late.

Pain Therapeutics, Inc. (NASDAQ:PTIE)

In today’s marketplace, there are a multitude of gauges investors can use to track their holdings. A couple of the most under-the-radar are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the top fund managers can trounce the S&P 500 by a solid amount (see just how much).

Just as beneficial, optimistic insider trading activity is another way to parse down the stock market universe. As the old adage goes: there are plenty of incentives for a corporate insider to downsize shares of his or her company, but just one, very obvious reason why they would buy. Plenty of empirical studies have demonstrated the useful potential of this method if piggybackers know where to look (learn more here).

With these “truths” under our belt, let’s take a peek at the key action encompassing Pain Therapeutics, Inc. (NASDAQ:PTIE).

What have hedge funds been doing with Pain Therapeutics, Inc. (NASDAQ:PTIE)?

Heading into 2013, a total of 11 of the hedge funds we track were bullish in this stock, a change of 10% from one quarter earlier. With the smart money’s sentiment swirling, there exists a few notable hedge fund managers who were increasing their holdings meaningfully.

Of the funds we track, Jacob Gottlieb’s Visium Asset Management had the most valuable position in Pain Therapeutics, Inc. (NASDAQ:PTIE), worth close to $12 million, comprising 0.4% of its total 13F portfolio. The second largest stake is held by Steven Owsley of Madison Street Partners, with a $5 million position; 0% of its 13F portfolio is allocated to the stock. Other hedgies that are bullish include Howard Guberman’s Gruss Asset Management, Jim Simons’s Renaissance Technologies and Jean-Marie Eveillard’s First Eagle Investment Management.

As industrywide interest jumped, some big names have jumped into Pain Therapeutics, Inc. (NASDAQ:PTIE) headfirst. Citadel Investment Group, managed by Ken Griffin, created the largest position in Pain Therapeutics, Inc. (NASDAQ:PTIE). Citadel Investment Group had 0 million invested in the company at the end of the quarter. Ken Griffin’s Citadel Investment Group also made a $0 million investment in the stock during the quarter.

What do corporate executives and insiders think about Pain Therapeutics, Inc. (NASDAQ:PTIE)?

Bullish insider trading is best served when the company in question has seen transactions within the past half-year. Over the last half-year time frame, Pain Therapeutics, Inc. (NASDAQ:PTIE) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s also take a look at hedge fund and insider activity in other stocks similar to Pain Therapeutics, Inc. (NASDAQ:PTIE). These stocks are Cytokinetics, Inc. (NASDAQ:CYTK), ArQule, Inc. (NASDAQ:ARQL), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), BioDelivery Sciences International, Inc. (NASDAQ:BDSI), and Amicus Therapeutics, Inc. (NASDAQ:FOLD). This group of stocks belong to the biotechnology industry and their market caps match PTIE’s market cap.

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Cytokinetics, Inc. (NASDAQ:CYTK) 7 0 1
ArQule, Inc. (NASDAQ:ARQL) 13 0 0
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) 6 1 0
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) 9 2 2
Amicus Therapeutics, Inc. (NASDAQ:FOLD) 8 2 0

With the returns exhibited by our strategies, retail investors should always monitor hedge fund and insider trading activity, and Pain Therapeutics, Inc. (NASDAQ:PTIE) is no exception.

Click here to learn why you should track hedge funds

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!